Evidence map›Paper›PMID 17646412›Full record

ArticleAntimicrobial agents and chemotherapy2007

Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae.

Ling-Xiang Zhu, Zhi-Wei Zhang, Dong Liang, Di Jiang, Can Wang, Ning Du, Qiong Zhang, Keith Mitchelson, Jing Cheng

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Antibiotic Resistance Mediated byAntibiotics (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
  5. Prevalence of ESBL and AmpC genes inNew microbes and new infections · 2022
    Article
  6. An advanced and efficient asymmetric PCR method for microarray applications.Frontiers in bioengineering and biotechnology · 2022
    Article
  7. Article
  8. TheInternational journal of genomics · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ling-Xiang ZhuMedical Systems Biology Research Center, Tsinghua University School of Medicine, Beijing, PR China.
Zhi-Wei Zhang
Dong Liang
Di Jiang
Can Wang
Ning Du
Qiong Zhang
Keith Mitchelson
Jing Cheng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multiplex asymmetric PCR (MAPCR)-based microarray method was developed for the detection of 10 known extended-spectrum beta-lactamases (ESBLs) and plasmid-mediated AmpC beta-lactamase genes in gram-negative bacteria and for the typing of six important point mutations (amino acid positions 35, 43, 130, 179, 238, and 240) in the bla(SHV) gene. The MAPCR is based on a two-round reaction to promote the accumulation of the single-stranded amplicons amenable for microarray hybridization by employing multiple universal unrelated sequence-tagged primers and elevating the annealing temperature at the second round of amplification. A strategy to improve the discrimination efficiency of the microarray was constituted by introducing an artificial mismatch into some of the allele-specific oligonucleotide probes. The microarray assay correctly identified the resistance genes in both the reference strains and some 111 clinical isolates, and these results were also confirmed for some isolates by direct DNA sequence analysis. The resistance genotypes determined by the microarray correlated closely with phenotypic MIC susceptibility testing. This fast MAPCR-based microarray method should prove useful for undertaking important epidemiological studies concerning ESBLs and plasmid-mediated AmpC enzymes and could also prove invaluable as a preliminary screen to supplement phenotypic testing for clinical diagnostics.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesChinaData Interpretation, StatisticalDNA PrimersDrug Resistance, BacterialElectrophoresis, Polyacrylamide GelEnterobacteriaceaeEnterobacteriaceae InfectionsGenes, BacterialGenotypeHumansMutationOligonucleotide Array Sequence AnalysisPoint MutationAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesDNA Primers

Identifiers

PMID17646412
PMCPMC2043267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.